as on February 27, 2026 at 9:31 pm IST
Day's Low
Day's High
2.49%
Downside
0.98%
Upside
52 Week's Low
52 Week's High
3.56%
Downside
53.47%
Upside
as on February 27, 2026 at 4:01 pm IST
Market Cap
₹273.07 Cr
Return on Equity (ROE)
7.9
PE Ratio (TTM)
14.23
Return on capital employed (ROCE)
10.25
Industry PE ratio
42.7
Beta (LTM)
0.77
P/B Ratio
1.53
Dividend Yield
0PEG Ratio
1422.78
Quarterly Earnings Growth YOY
18.15
EPS (TTM)
0.8
Sector
Pharmaceuticals
Book Value
7.96
Technical Analysis
Bearish
View Technical Analysis
as on February 27, 2026 at 4:01 pm IST
Gennex Laboratories in the last 5 years
Lowest (10.10x)
March 23, 2020
Today (14.23x)
February 27, 2026
Industry (42.70x)
February 27, 2026
Highest (86.13x)
August 3, 2018
Today’s Price to Earnings Ratio: 14.23x
Compare market cap, revenue, PE, and other key metrics of Gennex Laboratories with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 273.07 | 34.3% | 0.58 | 18 | 137 | |
| NA | 79.00 | 41.84% | 0.70 | 1 | 45 | |
| BUY | 15,437.18 | -4.25% | 0.57 | -18 | 1,444 | |
| BUY | 20,753.55 | -3.57% | 0.69 | 91 | 9,151 | |
| HOLD | 3,349.61 | -8.38% | 0.66 | 168 | 2,387 |
Investment in Gennex Laboratories Ltd Shares on INDmoney has grown by 11.17% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:11.17% versus previous 30 day period
Search interest for Gennex Laboratories Ltd Stock has decreased by -23% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Gennex Laboratories.
Gennex Laboratories Ltd’s net profit jumped 12.93% since last year same period to ₹5.24Cr in the Q3 2025-2026. On a quarterly growth basis, Gennex Laboratories Ltd has generated 4.17% jump in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 36.45 Cr → 42.96 Cr (in ₹), with an average increase of 7.9% per quarter
Profit Spike
![]()
Netprofit is up for the last 4 quarters, 2.32 Cr → 5.24 Cr (in ₹), with an average increase of 20.7% per quarter
Against Peers
![]()
In the last 1 year, Torrent Pharmaceuticals Ltd has given 47.3% return, outperforming this stock by 62.1%
Retail Holding Unchanged
![]()
Retail Investor holdings remained unchanged at 76.38% of holdings in Dec 2025 quarter
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 23.62% of holdings in Dec 2025 quarter
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 197.8% return, outperforming this stock by 75.8%
Price Dip
![]()
In the last 7 days, Gennex Lab. stock has moved down by -5.2%
| Organisation | Gennex Laboratories Ltd |
| Headquarters | Hyderabad |
| Industry | Pharmaceuticals |
| CEO | Arihant Baid |
| E-voting on shares | Click here to vote |
Gennex Laboratories share price today stands at ₹11.24 as on at the close of the market. Gennex Laboratories share today touched a day high of ₹11.35 and a low of ₹10.96.
Gennex Laboratories touched a 52 week high of ₹17.25 and a 52 week low of ₹10.84. Gennex Laboratories share price today i.e. is closed at ₹11.24, which is -34.84% down from its 52 week high and 3.69% up from its 52 week low.
Gennex Laboratories market capitalisation is ₹273.07 Cr as on .
To buy Gennex Laboratories shares, you need to follow these steps:
Gennex Laboratories trading volume is 2.81L as on . This means that 2.81L shares of Gennex Laboratories were bought and sold on the stock market during today's trading session.